BBVA USA’s Sarepta Therapeutics SRPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q3
$70K Sell
753
-406
-35% -$37.7K ﹤0.01% 601
2021
Q2
$90K Buy
+1,159
New +$90K 0.01% 570